US20170119519A1 - Device with a j-shaped end and with an inflatable balloon for use as support for devices for tissue reconstruction of excised tissues of the renal pelvis and/or of the ureteropelvic junction - Google Patents

Device with a j-shaped end and with an inflatable balloon for use as support for devices for tissue reconstruction of excised tissues of the renal pelvis and/or of the ureteropelvic junction Download PDF

Info

Publication number
US20170119519A1
US20170119519A1 US15/317,636 US201515317636A US2017119519A1 US 20170119519 A1 US20170119519 A1 US 20170119519A1 US 201515317636 A US201515317636 A US 201515317636A US 2017119519 A1 US2017119519 A1 US 2017119519A1
Authority
US
United States
Prior art keywords
support device
implant according
balloon
diameter
cannula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/317,636
Inventor
Antonio Sambusseti
Gianni CANCARINI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of US20170119519A1 publication Critical patent/US20170119519A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/008Implant devices for drainage of body fluids from one part of the body to another pre-shaped, for use in the urethral or ureteral tract
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/048Ureters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0067Three-dimensional shapes conical

Definitions

  • the present invention relates to a device with an end of the J type and provided with an inflatable balloon for use as support of devices for use in the replacement and reconstruction of tissues removed of the renal pelvis and/or of the ureteropelvic junction.
  • the present invention relates to such a device, similar to a stent one, to be used as support of a patch in resorbable fabric for use in the replacement and reconstruction of tissues of the renal pelvis and/or of the ureteropelvic junction in the case of stenosis, neoplasms or other types of diseases that obstruct the flow of urine.
  • the upper part of the ureter that in direct contact with the kidney, takes the name of renal pelvis and represents the anatomical entity which holds the urine produced by the kidney, conveying it into the ureter.
  • the renal pelvis has a shape roughly comparable to a funnel crushed in anteroposterior direction whose base turned upwards and outwards is divided into various recesses (calyces) which are held in the kidney while its narrowed end or apex is turned downwards, continuing into the ureter.
  • the point of connection between said renal pelvis and said ureter is defined as ureteropelvic junction.
  • the ureteropelvic junction has very often a narrowing which determines an obstacle to the normal flow of urine which goes to accumulate in the renal pelvis, causing the dilation thereof. This dilation causes a compression of the kidney with damage which can even lead to the functional loss of the same.
  • This remodelling which takes place by removing part of the tissue and performing successive sutures, to give thereto the shape and the dimension required, may be unsuitable in the case wherein the autologous tissues to be used for the reconstruction are weakened or thin for congenital or pathological reasons.
  • the renal pelvis is the site of serious neoplasms, such as urothelial carcinoma: in this case the necessary surgical removal of the portion of renal pelvis affected by the pathology entails a disadvantageous reduction in the volume of the pelvis.
  • US 2012/316656 describes a stent for treating the obstructions of a ureter comprising an elongated element which has a distal end, a proximal end and a medial portion placed between the two ones, wherein the medial portion is provided with an expandable element configured to be inserted in the ureter of the patient and configured to be in contact with the ureter to contribute to maintaining the elongated element in position inside the patient.
  • WO97/16218 describes a stent for treating the obstructions of a ureter and/or ureteropelvic junction comprising a system for treating the ureter and/or the ureteropelvic junction, comprising: means for widening an obstruction, means for guiding the widening means through the urethra, bladder and ureter, wherein the guide means can be introduced into the patient through the urethra, bladder and ureter to extend beyond the ureteropelvic junction.
  • the object of the present invention is that of overcoming, at least in part, the disadvantages of the prior art by providing a device for the replacement and regrowth of autologous tissues of renal pelvises and/or ureteropelvic junctions following stenosis, neoplasms or other types of diseases which obstruct the flow of urine.
  • An object of the present invention relates to a support device with a curled end and the other end provided with an inflatable balloon, for use as support in the tissue reconstruction and replacement of the renal pelvis and/or of the ureteropelvic junction, in association with a patch in resorbable fabric so as to facilitate the reconstruction, in the original form, of the removed tissues.
  • Said device including the balloon, is in flexible plastic material, for example polyurethane, silicone or another biocompatible material, and can also be in these materials but coated completely with pyrolytic turbostratic carbon so as to have a greater resistance to contact with urine.
  • flexible plastic material for example polyurethane, silicone or another biocompatible material
  • the device When the balloon is deflated, the device can be inserted along the ureter as far as the pelvis like a typical double-j stent remaining in position thanks to the curled tip which prevents the device from being displaced, once inserted in the bladder (similarly to an “autostatic” stent).
  • the balloon When the balloon is inflated, the device can conform to the removed part of the renal pelvis and/or of the ureteropelvic junction acting as support for a patch in bioabsorbable fabric, for example PGA, to be wound around this balloon and to be sutured to the edges of the tissue zone of the renal pelvis and/or of the ureteropelvic junction which has been removed.
  • the abovementioned device has found to be suitable for acting as scaffold or frame for a patch in resorbable fabric when the latter is covered by growing autologous cells generated by the process of tissue reconstruction of the patient, once the patch has been implanted in the patient.
  • the present stent device can remain in place for a brief period (days or weeks) or for a longer period of time (weeks or months) according to the extent of the zone removed.
  • FIG. 1 is a partially sectioned front view of a kidney
  • FIG. 2 is a front view of the stent-like device in accordance with the invention in the configuration of deflated balloon, where the inflated balloon of round shape has been shown as dotted;
  • FIG. 3 is a front view of the stent-like device in accordance with the invention where the inflated balloon has a conical shape;
  • FIGS. 4 a and 4 b are perspective views of the fabric and of the corresponding scaffold device to be used in association with the stent-like device in accordance with the invention.
  • FIGS. 1-4 a description is given of a support stent-like device for the replacement and reconstruction of tissues of the renal pelvis and/or of the ureteropelvic junction in accordance with the present invention, denoted overall by reference numeral 10 .
  • the stent support device 10 comprises a cannula 1 , substantially cylindrical and hollow, which extends from a proximal end 3 with a curled tip to a distal end 2 .
  • the curled tip 3 is apt to act as stop against the entrance of the ureter 7 , similarly to the double-j type stents, while the distal end 2 is intended to be inserted in the ureteropelvic junction and in the renal pelvis.
  • Said cannula 1 is constituted by two coaxial channels (not illustrated), arranged along its entire length: a first channel, more internal, is opened at the two ends so as to allow the urine to flow out along the ureter 7 towards the bladder, once the device 10 has been inserted in the ureter 7 .
  • the second channel is connected to a balloon, or cap, expandable, 5 , provided at the distal end 2 of the device 10 at its end section.
  • Said balloon 5 is suitable for being inflated with sterile bidistilled water or with sterile physiological solution, once placed inside the pelvis and/or the junction as will be described in detail here below.
  • This cap 5 and its ends are sealed on the cannula 1 according to known techniques used in the sector of medical devices, creating in this way an expandable chamber around said end section 2 of the cannula 1 .
  • the cap 5 is made in flexible and plastic material suitable for forming films, such as for example polyethylene (PE), with low or high density, polypropylene (PP), PVC free from phthalates (DEHP-free PVC), polyurethane (PU), silicone.
  • PE polyethylene
  • PP polypropylene
  • DEHP-free PVC PVC free from phthalates
  • PU polyurethane
  • Said cap 5 can also be subsequently coated with a microfilm of pyrolytic turbostratic carbon with thickness of approximately 0.2-0.3 microns.
  • the aforesaid materials can be used also to construct the cannula 1 of the device 10 , just as the coating with pyrolytic turbostratic carbon can be carried out also on the cannula 1 .
  • Said expandable cap 5 is in fluid communication with the more external channel of said cannula through one or more holes 6 placed only in the section of the more external channel which is surrounded by said cap 5 .
  • the increase in the diameter of said expandable chamber 5 finds a limit in the maximum diameter of expansion of said chamber which is defined by the manufacturer to occupy the zone of the pelvis without widening it.
  • the diameter of maximum expansion, or inflation, of said expandable cap 5 is such as to create a chamber with a capacity of about 70-100 cc.
  • the more internal channel also has holes provided along its entire length with the exception of the section where the balloon 5 is mounted: said holes have the purpose of facilitating the flow of urine from the pelvis 200 towards the bladder via the ureter 7 .
  • the present device generally has a length of about 26-30 cm (for adults) with a diameter of about 4-10 Ch, similarly to ureter catheters of the double-j or pigtail type.
  • First of all a surgical operation is carried out to remove the area of the pelvis 200 ( FIG. 1 ) affected by the stenosis, for example by cutting it in two distinct points along the same number of cutting planes C and D ( FIG. 1 ).
  • the device 10 with deflated balloon is inserted in the bladder and along the entire ureter 7 : once the section covered by the balloon 5 has reached the ureteropelvic junction or a zone of the pelvis 200 and the curled end 3 has stopped against the initial lumen of the ureter 7 , the expandable cap 5 is inflated up to the diameter of expansion required.
  • the removed stenotic zone can be reconstructed according to the following technique: a patch of resorbable fabric 20 ( FIG. 4 a ), for example in PGA, is wound around the balloon 5 so as to form a structure with similar shape to the removed zone, for example a truncated cone 100 ( FIG. 4 b ), then suturing the upper and lower edges of said truncated cone 100 to the edges of the tissue zone removed.
  • a patch of resorbable fabric 20 FIG. 4 a
  • a truncated cone 100 FIG. 4 b
  • the balloon 5 acts as support structure or frame for the truncated cone 100 formed by the resorbable fabric 20 , which is to be maintained in the position wherein it has been sutured until the reconstruction of the new tissue.
  • said truncated cone 100 is allowed to maintain this shape even under the weight of the growing new tissue of the renal pelvis and/or of the ureteropelvic junction above said truncated cone 100 .
  • the present device will be extracted.
  • a suture yarn in resorbable material is preferably used, with dimensions of approximately 4 / 0 , in order to have times of resorption similar to the patch in PGA fabric.
  • the holes of passage of the suture stitches in the natural tissue do not constitute a risk of leaks of liquid, in that in a few hours the tissue is reconstructed.
  • the holes of the suture stitches are in any case sealed and closed with one cc (a drop) of surgical glue, such as for example Glubran 2 TM, normally available commercially.

Landscapes

  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biophysics (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

A support device (10) includes a flexible cannula (1), substantially cylindrical and hollow, which extends from a curled proximal end (3) to a distal end (2) provided with an expandable balloon (5), for use as support of a conical device (100) constructed during a surgical operation from a patch in resorbable fabric (1), for use in the replacement and reconstruction of excised tissues of a renal pelvis and/or of a ureteropelvic junction so as to facilitate the tissue reconstruction thereof in the original form.

Description

  • The present invention relates to a device with an end of the J type and provided with an inflatable balloon for use as support of devices for use in the replacement and reconstruction of tissues removed of the renal pelvis and/or of the ureteropelvic junction.
  • More particularly the present invention relates to such a device, similar to a stent one, to be used as support of a patch in resorbable fabric for use in the replacement and reconstruction of tissues of the renal pelvis and/or of the ureteropelvic junction in the case of stenosis, neoplasms or other types of diseases that obstruct the flow of urine.
  • The upper part of the ureter, that in direct contact with the kidney, takes the name of renal pelvis and represents the anatomical entity which holds the urine produced by the kidney, conveying it into the ureter.
  • The renal pelvis has a shape roughly comparable to a funnel crushed in anteroposterior direction whose base turned upwards and outwards is divided into various recesses (calyces) which are held in the kidney while its narrowed end or apex is turned downwards, continuing into the ureter. The point of connection between said renal pelvis and said ureter is defined as ureteropelvic junction.
  • It happens at times that said pelvis and/or said ureteropelvic junction are affected by stenosis, neoplasms or other types of diseases which obstruct the flow of urine, therefore requiring a surgical operation.
  • For example the ureteropelvic junction has very often a narrowing which determines an obstacle to the normal flow of urine which goes to accumulate in the renal pelvis, causing the dilation thereof. This dilation causes a compression of the kidney with damage which can even lead to the functional loss of the same.
  • It is therefore necessary to provide, in this situation, a surgical operation of pyeloplasty, in order to remodel the ureteropelvic junction by removal of the stenotic segment and subsequent reconstructive plastic surgery so as to re-create a passage for the urine of adequate calibre.
  • This remodelling, which takes place by removing part of the tissue and performing successive sutures, to give thereto the shape and the dimension required, may be unsuitable in the case wherein the autologous tissues to be used for the reconstruction are weakened or thin for congenital or pathological reasons.
  • Much more rarely it may occur that the renal pelvis is the site of serious neoplasms, such as urothelial carcinoma: in this case the necessary surgical removal of the portion of renal pelvis affected by the pathology entails a disadvantageous reduction in the volume of the pelvis.
  • It is therefore highly desirable in the field of pathologies of the renal pelvis and/or of the ureteropelvic junction to have available a biocompatible device which can replace the stenotic tissue removed and which also allows the growth of the autologous tissue.
  • US 2012/316656 describes a stent for treating the obstructions of a ureter comprising an elongated element which has a distal end, a proximal end and a medial portion placed between the two ones, wherein the medial portion is provided with an expandable element configured to be inserted in the ureter of the patient and configured to be in contact with the ureter to contribute to maintaining the elongated element in position inside the patient.
  • WO97/16218 describes a stent for treating the obstructions of a ureter and/or ureteropelvic junction comprising a system for treating the ureter and/or the ureteropelvic junction, comprising: means for widening an obstruction, means for guiding the widening means through the urethra, bladder and ureter, wherein the guide means can be introduced into the patient through the urethra, bladder and ureter to extend beyond the ureteropelvic junction.
  • The object of the present invention is that of overcoming, at least in part, the disadvantages of the prior art by providing a device for the replacement and regrowth of autologous tissues of renal pelvises and/or ureteropelvic junctions following stenosis, neoplasms or other types of diseases which obstruct the flow of urine.
  • These and other objects are achieved by the device in accordance with the invention having the features listed in the appended independent claim 1.
  • Advantageous embodiments of the invention are disclosed by the dependent claims.
  • An object of the present invention relates to a support device with a curled end and the other end provided with an inflatable balloon, for use as support in the tissue reconstruction and replacement of the renal pelvis and/or of the ureteropelvic junction, in association with a patch in resorbable fabric so as to facilitate the reconstruction, in the original form, of the removed tissues.
  • Said device, including the balloon, is in flexible plastic material, for example polyurethane, silicone or another biocompatible material, and can also be in these materials but coated completely with pyrolytic turbostratic carbon so as to have a greater resistance to contact with urine.
  • When the balloon is deflated, the device can be inserted along the ureter as far as the pelvis like a typical double-j stent remaining in position thanks to the curled tip which prevents the device from being displaced, once inserted in the bladder (similarly to an “autostatic” stent). When the balloon is inflated, the device can conform to the removed part of the renal pelvis and/or of the ureteropelvic junction acting as support for a patch in bioabsorbable fabric, for example PGA, to be wound around this balloon and to be sutured to the edges of the tissue zone of the renal pelvis and/or of the ureteropelvic junction which has been removed.
  • In practice the abovementioned device has found to be suitable for acting as scaffold or frame for a patch in resorbable fabric when the latter is covered by growing autologous cells generated by the process of tissue reconstruction of the patient, once the patch has been implanted in the patient.
  • After having inflated the balloon, the present stent device can remain in place for a brief period (days or weeks) or for a longer period of time (weeks or months) according to the extent of the zone removed.
  • Further features of the invention will be made clearer by the following detailed description, referred to a purely non-limiting example thereof, illustrated in the accompanying drawings in which:
  • FIG. 1 is a partially sectioned front view of a kidney;
  • FIG. 2 is a front view of the stent-like device in accordance with the invention in the configuration of deflated balloon, where the inflated balloon of round shape has been shown as dotted;
  • FIG. 3 is a front view of the stent-like device in accordance with the invention where the inflated balloon has a conical shape;
  • FIGS. 4a and 4b are perspective views of the fabric and of the corresponding scaffold device to be used in association with the stent-like device in accordance with the invention.
  • With the aid of FIGS. 1-4 a description is given of a support stent-like device for the replacement and reconstruction of tissues of the renal pelvis and/or of the ureteropelvic junction in accordance with the present invention, denoted overall by reference numeral 10.
  • The stent support device 10 comprises a cannula 1, substantially cylindrical and hollow, which extends from a proximal end 3 with a curled tip to a distal end 2.
  • The curled tip 3 is apt to act as stop against the entrance of the ureter 7, similarly to the double-j type stents, while the distal end 2 is intended to be inserted in the ureteropelvic junction and in the renal pelvis.
  • Said cannula 1 is constituted by two coaxial channels (not illustrated), arranged along its entire length: a first channel, more internal, is opened at the two ends so as to allow the urine to flow out along the ureter 7 towards the bladder, once the device 10 has been inserted in the ureter 7.
  • The second channel, more external, is connected to a balloon, or cap, expandable, 5, provided at the distal end 2 of the device 10 at its end section.
  • Said balloon 5 is suitable for being inflated with sterile bidistilled water or with sterile physiological solution, once placed inside the pelvis and/or the junction as will be described in detail here below.
  • This cap 5 and its ends are sealed on the cannula 1 according to known techniques used in the sector of medical devices, creating in this way an expandable chamber around said end section 2 of the cannula 1.
  • The cap 5 is made in flexible and plastic material suitable for forming films, such as for example polyethylene (PE), with low or high density, polypropylene (PP), PVC free from phthalates (DEHP-free PVC), polyurethane (PU), silicone.
  • Said cap 5 can also be subsequently coated with a microfilm of pyrolytic turbostratic carbon with thickness of approximately 0.2-0.3 microns.
  • It is understood that the aforesaid materials can be used also to construct the cannula 1 of the device 10, just as the coating with pyrolytic turbostratic carbon can be carried out also on the cannula 1.
  • Said expandable cap 5 is in fluid communication with the more external channel of said cannula through one or more holes 6 placed only in the section of the more external channel which is surrounded by said cap 5.
  • Via said through holes 6 it is therefore possible to expand partially or completely the closed chamber after having injected a fluid, for example a physiological solution, inside the more external channel of the cannula 1.
  • It should be noted that the length of the more external channel section surrounded by said cap 5 is not binding for the purpose of the present invention.
  • The increase in the diameter of said expandable chamber 5 finds a limit in the maximum diameter of expansion of said chamber which is defined by the manufacturer to occupy the zone of the pelvis without widening it.
  • The diameter of maximum expansion, or inflation, of said expandable cap 5 is such as to create a chamber with a capacity of about 70-100 cc.
  • The abovementioned measurements are only indicative and not limiting for the purpose of the present invention.
  • The more internal channel also has holes provided along its entire length with the exception of the section where the balloon 5 is mounted: said holes have the purpose of facilitating the flow of urine from the pelvis 200 towards the bladder via the ureter 7.
  • The present device generally has a length of about 26-30 cm (for adults) with a diameter of about 4-10 Ch, similarly to ureter catheters of the double-j or pigtail type.
  • A description will now be given of the procedure of use of the present device 10 in an operation.
  • First of all a surgical operation is carried out to remove the area of the pelvis 200 (FIG. 1) affected by the stenosis, for example by cutting it in two distinct points along the same number of cutting planes C and D (FIG. 1).
  • After which, during the operation, the device 10 with deflated balloon is inserted in the bladder and along the entire ureter 7: once the section covered by the balloon 5 has reached the ureteropelvic junction or a zone of the pelvis 200 and the curled end 3 has stopped against the initial lumen of the ureter 7, the expandable cap 5 is inflated up to the diameter of expansion required.
  • Once the chamber 5 of the device 10 has been inflated, the removed stenotic zone can be reconstructed according to the following technique: a patch of resorbable fabric 20 (FIG. 4a ), for example in PGA, is wound around the balloon 5 so as to form a structure with similar shape to the removed zone, for example a truncated cone 100 (FIG. 4b ), then suturing the upper and lower edges of said truncated cone 100 to the edges of the tissue zone removed.
  • In this case the balloon 5 acts as support structure or frame for the truncated cone 100 formed by the resorbable fabric 20, which is to be maintained in the position wherein it has been sutured until the reconstruction of the new tissue. In this way said truncated cone 100 is allowed to maintain this shape even under the weight of the growing new tissue of the renal pelvis and/or of the ureteropelvic junction above said truncated cone 100.
  • Once the tissue of the pelvis has been reconstructed, generally in around 1 month, the present device will be extracted.
  • For the sutures a suture yarn in resorbable material (PGA) is preferably used, with dimensions of approximately 4/0, in order to have times of resorption similar to the patch in PGA fabric.
  • The holes of passage of the suture stitches in the natural tissue do not constitute a risk of leaks of liquid, in that in a few hours the tissue is reconstructed. To avoid leaks of urine (liquid), the holes of the suture stitches are in any case sealed and closed with one cc (a drop) of surgical glue, such as for example Glubran 2TM, normally available commercially.
  • As patch in PGA fabric, the one described by the Applicant in the patent application MI2009A002093, incorporated here in full for reference, can be used for example.
  • The present invention is not limited to the particular embodiments previously described and illustrated in the accompanying drawings, but numerous detailed changes may be made thereto, within the reach of the person skilled in the art, without thereby departing from the scope of the invention itself as defined in the appended claims.

Claims (21)

1-10. (canceled)
11. Implant for use in the tissue reconstruction and replacement of excised tissues of a renal pelvis and/or of a ureteropelvic junction so as to facilitate the reconstruction thereof in the original natural form, said implant comprising
(A) a support device (10) provided with a shaped end of j-type comprising flexible cannula (1) substantially cylindrical and hollow, which extends from a curled proximal end (3) having a (j) shape to a distal end (2) provided with an expandable balloon (5)
(B) a resorbable conical device (100) constructed during an operation from a patch in resorbable fabric (20) and wound around said balloon (5) of said support device (10),
said resorbable conical device (100) being for use in the tissue reconstruction and replacement of excised tissues of a renal pelvis and/or of a ureteropelvic junction so as to facilitate the reconstruction thereof in the original natural form,
wherein said cannula (1) of said support (10) is constituted by two coaxial channels arranged along its entire length,
a first, more internal channel, being open at the two ends for the flow of urine from the kidney to the bladder;
a second, more external channel, being in fluid communication with said expandable balloon (5).
12. Implant according to claim 11, wherein said support device (10) is made in a flexible plastic material.
13. Implant according to claim 12, wherein the plastic material of said support—device (10) is selected from low or high density polyethylene (PE), polypropylene (PP), PVC, phthalates-free PVC (DEHP free PVC), polyurethane (PU), silicone.
14. Implant according to claim 11, wherein said expandable balloon (5) of said support device (10) is in fluid communication with the more external channel of said cannula (1) through one or more holes (6) arranged on said more external channel only at the section thereof surrounded by said balloon (5) .
15. Implant according to claim 11, wherein the diameter of maximum expansion, or inflation, of said balloon (5) of said support device (10) is such as to create a chamber with a capacity of about 70-100 cc.
16. Implant according to claim 11, wherein the length of said support device (10) is about 26-30 cm (for adults) with a diameter of about 4-10 Ch.
17. Implant according to claim 12, wherein the flexible plastic material of said support device (10) is coated completely with pyrolytic turbostratic carbon.
18. Implant according to claim 13, wherein the plastic material of said support device (10) is polyurethane or silicone.
19. Implant according to claim 13, wherein the plastic material of said support device (10) is coated with a microfilm of pyrolytic turbostratic carbon with a thickness of approximately 0.2-0.3 microns.
20. Device (10) provided with a j-shaped end for supporting a resorbable conical device (100) for use in the tissue reconstruction and replacement of excised tissues of a renal pelvis (200) and/or of a ureteropelvic junction so as to facilitate the reconstruction thereof in the original natural form,
said support device (10) comprising
a flexible cannula (1), substantially cylindrical and hollow, which extends from a curled proximal end (3) having said (j) shape to a distal end (2) provided with an expandable balloon (5), said cannula (1) being constituted by two channels arranged along its entire length,
the first, more internal channel, being open at the two ends for the flow of urine from the kidney to the bladder,
the second, more external channel, being in fluid communication with said expandable balloon (5) through one or more holes (6) arranged on said more external channel only at the section thereof surrounded by said balloon (5),
wherein
the two channels of said cannula (1) are coaxial, and
the first, more internal channel, has also holes along its entire length with the exception of the section where the balloon (5) is mounted in order to facilitate the flow of urine from said pelvis (200) towards the bladder via ureter.
21. Implant according to claim 12, wherein said expandable balloon (5) of said support device (10) is in fluid communication with the more external channel of said cannula (1) through one or more holes (6) arranged on said more external channel only at the section thereof surrounded by said balloon (5).
22. Implant according to claim 13, wherein said expandable balloon (5) of said support device (10) is in fluid communication with the more external channel of said cannula (1) through one or more holes (6) arranged on said more external channel only at the section thereof surrounded by said balloon (5).
23. Implant according to claim 12, wherein the diameter of maximum expansion, or inflation, of said balloon (5) of said support device (10) is such as to create a chamber with a capacity of about 70-100 cc.
24. Implant according to claim 13, wherein the diameter of maximum expansion, or inflation, of said balloon (5) of said support device (10) is such as to create a chamber with a capacity of about 70-100 cc.
25. Implant according to claim 14, wherein the diameter of maximum expansion, or inflation, of said balloon (5) of said support device (10) is such as to create a chamber with a capacity of about 70-100 cc.
26. Implant according to claim 12, wherein the length of said support device (10) is about 26-30 cm (for adults) with a diameter of about 4-10 Ch.
27. Implant according to claim 13, wherein the length of said support device (10) is about 26-30 cm (for adults) with a diameter of about 4-10 Ch.
28. Implant according to claim 14, wherein the length of said support device (10) is about 26-30 cm (for adults) with a diameter of about 4-10 Ch.
29. Implant according to claim 15, wherein the length of said support device (10) is about 26-30 cm (for adults) with a diameter of about 4-10 Ch.
30. Implant according to claim 17, wherein the plastic material of said support device (10) is polyurethane or silicone.
US15/317,636 2014-06-12 2015-06-08 Device with a j-shaped end and with an inflatable balloon for use as support for devices for tissue reconstruction of excised tissues of the renal pelvis and/or of the ureteropelvic junction Abandoned US20170119519A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20141070 2014-06-12
ITMI2014A001070 2014-06-12
PCT/EP2015/062734 WO2015189156A1 (en) 2014-06-12 2015-06-08 Device with a j-shaped end and with an inflatable balloon for use as support for devices for tissue reconstruction of excised tissues of the renal pelvis and/or of the ureteropelvic junction

Publications (1)

Publication Number Publication Date
US20170119519A1 true US20170119519A1 (en) 2017-05-04

Family

ID=51454784

Family Applications (1)

Application Number Title Priority Date Filing Date
US15/317,636 Abandoned US20170119519A1 (en) 2014-06-12 2015-06-08 Device with a j-shaped end and with an inflatable balloon for use as support for devices for tissue reconstruction of excised tissues of the renal pelvis and/or of the ureteropelvic junction

Country Status (15)

Country Link
US (1) US20170119519A1 (en)
EP (1) EP3154621A1 (en)
JP (1) JP6533573B2 (en)
KR (1) KR101971511B1 (en)
CN (1) CN106456947A (en)
AP (1) AP2016009620A0 (en)
BR (1) BR112016029059A2 (en)
CA (1) CA2949427A1 (en)
EA (1) EA201692524A1 (en)
IL (1) IL249060A0 (en)
MA (1) MA39884A (en)
MX (1) MX2016015784A (en)
TN (1) TN2016000552A1 (en)
WO (1) WO2015189156A1 (en)
ZA (1) ZA201608557B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10610664B2 (en) 2015-07-20 2020-04-07 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10765834B2 (en) * 2015-07-20 2020-09-08 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10799668B2 (en) 2015-07-20 2020-10-13 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11040180B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Systems, kits and methods for inducing negative pressure to increase renal function
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US11471583B2 (en) 2015-07-20 2022-10-18 Roivios Limited Method of removing excess fluid from a patient with hemodilution
US11541205B2 (en) 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10573910B2 (en) 2015-09-14 2020-02-25 Bloom Energy Corporation Electrochemical impedance spectroscopy (“EIS”) analyzer and method of using thereof
CN113908411A (en) * 2021-10-20 2022-01-11 武汉威润八方医疗科技有限公司 Integrated ureteral stent

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010032013A1 (en) * 1999-11-19 2001-10-18 Denes Marton Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US20020106549A1 (en) * 2000-10-23 2002-08-08 The Regents Of The University Of California Fuel cell apparatus and method thereof
US20100032013A1 (en) * 2008-08-08 2010-02-11 Andreas Krause Semiconductor component
US20120290065A1 (en) * 2011-05-12 2012-11-15 Boston Scientific Scimed Inc. Pre-Positioned Anastomosis Device and Related Methods of Use
US20140142721A1 (en) * 2012-04-10 2014-05-22 Boston Scientific Scimed, Inc. Ureteral stent with drug delivery reservoir
US20150134073A1 (en) * 2013-11-12 2015-05-14 Gyrus Acmi, Inc. Ureteral stents with waveform interlayers and interstitching

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055786A1 (en) * 1994-08-16 2002-05-09 Anthony Atala Reconstruction of urological structures with polymeric matrices
NL1001564C2 (en) * 1995-11-02 1997-05-13 Timotheus Theodorus Cornelis O System of devices for treating the ureter and / or the pyelo-ureter junction.
US6227202B1 (en) * 1996-09-03 2001-05-08 Maulana Azad Medical College Method of organogenesis and tissue regeneration/repair using surgical techniques
EP1727583A1 (en) * 2004-03-23 2006-12-06 Boston Scientific Limited Agent eluting stent and catheter
EP2150284A2 (en) * 2007-04-26 2010-02-10 Advanced Technologies and Regenerative Medicine, LLC Tissue engineering devices and methods for luminal organs
IT1392503B1 (en) * 2009-01-07 2012-03-09 Sambusseti ORTHOTOPIC ENDOPROSTHESIS OF ARTIFICIAL BLADDER
US10219889B2 (en) * 2011-06-10 2019-03-05 Boston Scientific Scimed, Inc. Balloon expandable ureteral stent
EP3517145A1 (en) * 2012-02-08 2019-07-31 Boston Scientific Scimed, Inc. Surgical scaffolds
CN202459806U (en) * 2012-02-29 2012-10-03 张波 Ureter tissue chronic dilator
ITMI20120646A1 (en) * 2012-04-18 2013-10-19 Sambusseti Antonio PERMANENT TUBULAR DEVICE FOR THE RECONSTRUCTION OF A URETHRAL OR URETERAL SEGMENT MADE OF SILICONE COATED WITH TURBOSTRIC PYROLYTIC CARBON
US20140052272A1 (en) * 2012-08-20 2014-02-20 Boston Scientific Scimed, Inc. Comfort stents

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010032013A1 (en) * 1999-11-19 2001-10-18 Denes Marton Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US20020106549A1 (en) * 2000-10-23 2002-08-08 The Regents Of The University Of California Fuel cell apparatus and method thereof
US20100032013A1 (en) * 2008-08-08 2010-02-11 Andreas Krause Semiconductor component
US20120290065A1 (en) * 2011-05-12 2012-11-15 Boston Scientific Scimed Inc. Pre-Positioned Anastomosis Device and Related Methods of Use
US20140142721A1 (en) * 2012-04-10 2014-05-22 Boston Scientific Scimed, Inc. Ureteral stent with drug delivery reservoir
US20150134073A1 (en) * 2013-11-12 2015-05-14 Gyrus Acmi, Inc. Ureteral stents with waveform interlayers and interstitching

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10610664B2 (en) 2015-07-20 2020-04-07 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10765834B2 (en) * 2015-07-20 2020-09-08 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10799668B2 (en) 2015-07-20 2020-10-13 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
US10918825B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11040180B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Systems, kits and methods for inducing negative pressure to increase renal function
US11077284B2 (en) 2015-07-20 2021-08-03 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US11420014B2 (en) 2015-07-20 2022-08-23 Roivios Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11471583B2 (en) 2015-07-20 2022-10-18 Roivios Limited Method of removing excess fluid from a patient with hemodilution
US11541205B2 (en) 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US11612714B2 (en) 2015-07-20 2023-03-28 Roivios Limited Systems and methods for inducing negative pressure in a portion of a urinary tract of a patient
US11752300B2 (en) 2015-07-20 2023-09-12 Roivios Limited Catheter device and method for inducing negative pressure in a patient's bladder
US11896785B2 (en) 2015-07-20 2024-02-13 Roivios Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11904113B2 (en) 2015-07-20 2024-02-20 Roivios Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11904121B2 (en) 2015-07-20 2024-02-20 Roivios Limited Negative pressure therapy system
US11918754B2 (en) 2015-07-20 2024-03-05 Roivios Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion

Also Published As

Publication number Publication date
ZA201608557B (en) 2018-05-30
TN2016000552A1 (en) 2018-04-04
JP2017517372A (en) 2017-06-29
KR20170018039A (en) 2017-02-15
CN106456947A (en) 2017-02-22
JP6533573B2 (en) 2019-06-19
MA39884A (en) 2015-12-17
WO2015189156A1 (en) 2015-12-17
AP2016009620A0 (en) 2016-12-31
CA2949427A1 (en) 2015-12-17
KR101971511B1 (en) 2019-04-23
BR112016029059A2 (en) 2017-08-22
EP3154621A1 (en) 2017-04-19
MX2016015784A (en) 2017-07-28
EA201692524A1 (en) 2017-06-30
IL249060A0 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
US20170119519A1 (en) Device with a j-shaped end and with an inflatable balloon for use as support for devices for tissue reconstruction of excised tissues of the renal pelvis and/or of the ureteropelvic junction
KR101814855B1 (en) Improved surgical implant devices and methods for their manufacture and use
US20220288363A1 (en) Endovascular Cerebrospinal Fluid Shunt
US10596357B2 (en) Endovascular cerebrospinal fluid shunt
US10219889B2 (en) Balloon expandable ureteral stent
CN101917928B (en) Partial cuff
BRPI0706904A2 (en) implantable graft set and aneurysm treatment
JP2008513132A (en) Tissue augmentation device
JP6672164B2 (en) Orthotopic prosthesis endoprosthesis and orthotopic prosthesis endoprosthesis kit
WO2020060587A1 (en) Medical occlusion device
US20170216068A1 (en) Anti-migration stent deployment delivery systems and methods
US20210204961A1 (en) Medical occlusion device
JP2021079270A (en) Stent graft device comprising anchor member comprising adjustable geometry
CN109152636A (en) Filter, block system and associated method and apparatus
OA18128A (en) Device with a J-shaped end and with an inflatable balloon for use as support for devices for tissue reconstruction of excised tissues of the renal pelvis and/or of the ureteropelvic junction
CN219629681U (en) Plugging device and plugging system
US20160045301A1 (en) Implant device for use in salivary gland duct
ES2361470T3 (en) IMPLANTABLE DEVICE.
US20180078407A1 (en) System, device and method for treatment of endometriosis
JP2016067697A (en) Urethral stenosis treatment device and urethral stenosis treatment method
CN118021371A (en) Plugging device and plugging system
ES2735515T3 (en) Implantable device for approximation of anatomical structures in particular in the treatment of hiatal hernia
JP2016067677A (en) Indwelling device

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION